Work

Phase II Trial Of Bortezomib In Combination With Fractionated Cyclophosphamide and Rituximab (BCR) For Relapsed/Refractory Mantle Cell Lymphoma (MCL)

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.5122.5122

Authors: Jorge E Romaguera, Michelle A. Fanale, Felipe Samaniego, Luis E Fayad, Fredrick B Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Pam Weaver, Kim Hartig, Maria Badillo, Larry W. Kwak, Anas Younes, Barbara Pro, Michael Wang

Institutions: The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Thomas Jefferson University Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2469989577

FWCI:

Cites:

Cited by:

Related to: 10